Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Receiver operating characteristic and Oncology, with related work in Proportional hazards model, Erythropoietin-producing hepatocellular (Eph) receptor, EPH receptor A2. Notable publications include 'A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis In Vivo', 'Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma', and 'Post-operative radiotherapy is beneficial for T1/T2 triple negative breast cancer patients with four or more positive lymph nodes'.
Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial
Construction of a Six-Gene Prognostic Risk Model Related to Hypoxia and Angiogenesis for Cervical Cancer
Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma
Post-operative radiotherapy is beneficial for T1/T2 triple negative breast cancer patients with four or more positive lymph nodes
A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis In Vivo